Menu
Recruiting NCT06381388

Interaction Between the Brain Hemispheres - Key to Motor Recovery After Stroke

No phase Interventional Stroke

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: cTBS.
Who it may be relevant to
Registry conditions: Stroke. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Netherlands
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Rationale: Acute stroke leaves many patients with functional deficits, of which upper extremity motor impairment is one of the most disabling. Evidence from imaging and electrophysiological studies converge on the idea that impaired motor function after stroke is associated with disrupted network activity in the brain. Non-invasive brain stimulation methods, like transcranial magnetic stimulation (TMS), can be used to restore disrupted network activity and have been shown to successfully facilitate recovery of motor function in patients with stroke. Application of continuous theta burst stimulation (cTBS), an inhibitory form of TMS, to the contralesional motor cortex has been shown to improve the recovery of motor function in patients with stroke. However, responsiveness to this treatment varies considerably between stroke patients and the mechanisms through which contralesional cTBS facilitates recovery of motor function remain unclear. Objective: To determine if contralesional cTBS normalizes interhemispheric inhibition from the contralesional to ipsilesional primary motor cortex stroke patients with motor impairments. Age-matched healthy persons will serve as controls. Study design: A prospective, open-label within-subject intervention study Study population: 40 patients with first-ever ischemic stroke in one hemisphere and a unilateral paresis of the upper extremity, and 40 age-matched controls. Main endpoints: Primary endpoint: Interhemispheric inhibition from the contralesional to ipsilesional primary motor cortex. Secondary endpoints: contralesional intracortical inhibition; effect of contralesional TMS interference on finger tapping frequency.

Interventions

  • Device cTBS
    A single cTBS session delivered to the contralesional primary motor cortex.

Primary outcome measures

  • Interhemispheric inhibition (IHI) [Time frame: Within 30 minutes after cTBS]
Secondary outcome measures (4)
  • Ipsilesional resting motor threshold (RMT) [Time frame: Within 30 minutes after cTBS]
  • Contralesional resting motor threshold (RMT) [Time frame: Within 30 minutes after cTBS]
  • TMS interference [Time frame: Within 30 minutes after cTBS]
  • Intracortical inhibition (ICI) [Time frame: Within 30 minutes after cTBS]

Eligibility criteria

Inclusion Criteria for patients:

  • Age ≥ 18 years;
  • First-ever ischemic stroke or intracerebral hemorrhage in a cerebral hemisphere or the brainstem;
  • Unilateral paresis of an upper extremity with a Motricity Index (MI) between 9 and 99
  • Inclusion possible between 3 weeks and 6 weeks after stroke onset;
  • Signed informed consent.

Inclusion Criteria for healthy controls:

  • Age ≥ 18 years;
  • Signed informed consent.
  • Normal motor function with a minimum Motricity Index (MI) of 99.

Exclusion criteria

  • Disabling medical conditions (severe heart disease, severe head trauma, severe mental illness);
  • Severe deficits in communication, memory or understanding which could impede participation, as determined by the treating physician;
  • Contraindications to TMS and/or MRI (ferrous implants, history of epilepsy, drug or alcohol abuse over a period of 6 months prior to the experiment, pregnancy);
  • Life expectancy shorter than one year;
  • Upper limb paresis prior to stroke onset.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Other

Study locations

Netherlands · 1 center
  • De Hoogstraat Revalidatie — Utrecht

Identifiers

NCT: NCT06381388 · NL86587.041.24

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗